MedTrace Logo

I-Gel in Out-of-hospital Cardiac Arrest in Norway

NCT02090218 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2024-02-09

No results posted yet for this study

Summary

The main objective of this trial is to compare the effectiveness of a newer supraglottic airway method (the i-Gel), compared to current airway management practice in out-of-hospital cardiac arrests treated by Norwegian ambulance services.

Conditions

  • Out of Hospital Cardiac Arrest

Interventions

DEVICE

I-Gel

I-Gel supraglottic airway device

DEVICE

LTS, ETI or current airway management practice

Laryngeal tube, endotracheal tube, bag-mask-ventilation

Sponsors & Collaborators

  • Sykehuset Innlandet HF

    collaborator OTHER

  • Helse Midt-Norge

    collaborator OTHER

  • Helse Fonna

    collaborator OTHER

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Geir A Sunde, MD · Haukeland University Hospital

  • Jon-Kenneth Heltne, MD, PhD · Haukeland University Hospital

  • Guttorm Brattebø, MD · Haukeland University Hospital

  • Hanne Klausen, MD · Haukeland University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02090218 on ClinicalTrials.gov